Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery

Protein-protein interactions (PPIs) are an effective means to orchestrate intricate biological processes required to sustain life. Approximately 650000 PPIs underlie the human interactome; thus underscoring its complexity and the manifold signaling outputs altered in response to changes in specific PPIs. This minireview illustrates the growing arsenal of PPI assemblies and offers insights into how these varied PPI regulatory modalities are relevant to customized drug discovery, with a focus on cancer. First, known and emerging PPIs and PPI-targeted drugs of both natural and synthetic origin are categorized. Building on these discussions, the merits of PPI-guided therapeutics over traditional drug design are discussed. Finally, a compare-and-contrast section for different PPI blockers, with gain-of-function PPI interventions, such as PROTACS, is provided.


Published in:
Chembiochem, 20, 9, 1091-1104
Year:
May 02 2019
Publisher:
Weinheim, WILEY-V C H VERLAG GMBH
ISSN:
1439-4227
1439-7633
Keywords:
Laboratories:




 Record created 2019-06-28, last modified 2019-08-06


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)